CASP1 and hepatocellular carcinoma: The serum levels of caspase-1 in CHB, ACLF, LC and HCC were significantly decreased compared with normal subjects, and the serum level of caspase-1 in ACLF was the lowest among the four patient groups (Fig. 2a).